✦ LIBER ✦

PCV60 Cost-Effectiveness of Dabigatran for the Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Australia

✍ Scribed by D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV56 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV60 Cost Effectiveness of Dabigatran E

✍ S. Kececioglu; P. Ulus; F. Cukadar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV48 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; S.C.O. Martins; L.S.P. Piegas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV72 Cost-Effectiveness of Rivaroxaban

✍ G. Restovic; D. Carcedo; E.J. McLeod; A.L.G. Guillermin; T. Evers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV54 Cost-Effectiveness Analysis of Dab

✍ M.A. Ward; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB